Why the study?
What are the comparative hemodynamic effects of different vasopressor and vasodilator drugs used in circulatory shock?
What are the comparative hemodynamic effects of different vasopressor and vasodilator drugs used in circulatory shock?
Viewing the effects of vasoactive drugs as a hemodynamic spectrum, rather than just by their pressor response, resolves the apparent paradox between vasopressor and vasodilator therapy in circulatory shock.
Answers are grounded in this paper and cite their sources.
Supports spectrum-based vasoactive drug selection in shock; leaves open optimal choices pending randomized trials.
Hemodynamic effects of vasopressor agents and vasodilator drugs were compared in order to clarify differences which would be of practical significance for their use in treatment of circulatory shock. The alpha-adrenergic agents, methoxamine and phenylephrine hydrochloride, increased arterial pressure and decreased heart rate and venous return. The beta-adrenergic agents, mephentermine and isoproterenol hydrochloride, and the alphaadrenergic blocking agents, phentolamine mesylate and phenoxybenzamine hydrochloride, produced similar hemodynamic effects. Both groups of drugs increased heart rate and venous return. An intermediate response was observed with epinephrine, levarterenol bitartrate, and metaraminol bitartrate, drugs which havebothalphaand beta-adrenergic actions. In these studies, the limited significance of a classification which is based on the pressor response became apparent. When the effects are viewed as a spectrum of hemodynamic actions, the apparent paradox between vasopressor and vasodilator therapy for shock is largely resolved.
No takes yet. Share an insight, caveat, or question.
Calton M. Lewis (1969) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: